Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario
AUTOR(ES)
Clarke, Joe T.R.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=81418Documentos Relacionados
- Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
- Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
- Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.
- Enzyme Replacement in Gaucher Disease
- Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.